triparanol has been researched along with u 18666a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartl, N; Bracher, F; Giera, M; Hemmers, S; Körner, A; Mirakaj, V; Müller, C; Plodek, A | 1 |
| Boogaard, A; Cohen, LH; Griffioen, M | 1 |
2 other study(ies) available for triparanol and u 18666a
| Article | Year |
|---|---|
New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
Topics: Animals; Desmosterol; Enzyme Inhibitors; HL-60 Cells; Humans; Inhibitory Concentration 50; Mice; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Spectrum Analysis | 2017 |
Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
Topics: Androstenes; Animals; Anticholesteremic Agents; Carcinoma, Hepatocellular; Cell Line; Cholesterol; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Imidoesters; Lipid Metabolism; Liver Neoplasms; Lovastatin; Mevalonic Acid; Naphthalenes; Triparanol | 1987 |